LORRAINE CALVERT: Open Payments
NPI 1730166778 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 115 payments from 29 companies in 2025. Trend: 2023 $2,302 · 2024 $1,794 · 2025 $2,121
Food & beverage: $2,121
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 17 | $214 |
| Lilly USA, LLC | 12 | $191 |
| Amgen Inc. | 9 | $152 |
| Amneal Pharmaceuticals LLC | 8 | $149 |
| Tandem Diabetes Care, Inc. | 4 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Sequel Med Tech, LLC | 5 | $90 |
| BETA BIONICS, INC. | 5 | $85 |
| Mannkind Corporation | 4 | $84 |
| Astellas Pharma US Inc | 4 | $83 |
Products named: MINIMED 780G, UNITHROID, t:slim X2 Insulin Pump with Control-IQ, EVENITY, MOUNJARO, LEQVIO, TWIIST, iLet Bionic Pancreas.
Industry payments across IN — which companies pay providers there.
